Item 1. Legal Proceedings
Item 1. Legal Proceedings
Refer to “Note 6 – Litigation,” to the condensed consolidated financial statements included in Part I, Item 1 of this report for information regarding legal proceedings in which we are involved.
Item 1A. Ri sk Factors
There have been no material changes in the risk factors that were included in our Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the SEC on February 26, 2026.
Ite m 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table summarizes information related to stock repurchases during the quarter ended March 31, 2026.
Month
Total Number of
Shares
Repurchased
Average Price
Paid Per Share (1)
Total Number
of Shares
Repurchased
as Part of
Publicly
Announced Plan (2)
Approximate
Dollar Value of
Shares that
May Yet Be
Repurchased
Under the Plan
(in thousands) (2)
Jan 1 - Jan 31, 2026
41,500
$
38.76
41,500
$
73,819
Feb 1 - Feb 28, 2026
—
$
—
—
$
73,819
Mar 1 - Mar 31, 2026
659,426
$
28.05
659,426
$
55,325
Total
700,926
700,926
(1) Average price paid per share includes commissions paid to our broker and excludes excise taxes incurred on share repurchases.
(2) On August 4, 2025, the Board of Directors authorized the repurchase of up to $100.0 million of the Company’s common stock over a two-year period beginning August 4, 2025. As of March 31, 2026, the Company had repurchased 1,310,988 shares at an aggregate purchase price of $44.7 million.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.